| Issue |
Section |
Title |
File |
| Vol 46, No 5 (2018) |
GUIDELINES |
A draft of the interdisciplinary guidelines for diagnosis, methods for assessment of the degree of inflammatory activity, therapeutic efficacy, and for the use of biological agents in patients with concomitant immunoinflammatory diseases (psoriasis, psoriatic arthritis, Crohn's disease) |
(Rus)
|
| Vol 46, No 5 (2018) |
ARTICLES |
Social and demographic characteristics, features of disease course and treatment options of inflammatory bowel disease in Russia: results of two multicenter studies |
(Rus)
|
| Vol 46, No 5 (2018) |
CLINICAL CASES |
A rare case of fever as the main symptom of Crohn's disease manifestation |
(Rus)
|
| Vol 47, No 8 (2019) |
REVIEW ARTICLE |
Anemia in inflammatory bowel diseases: the approaches to its diagnosis, treatment and prevention |
(Rus)
|
| Vol 48, No 6 (2020) |
CLINICAL GUIDELINES |
Early administration of genetically engineered biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An experts’ opinion |
(Rus)
|
| Vol 49, No 7 (2021) |
ARTICLES |
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study |
(Rus)
|
| Vol 49, No 7 (2021) |
POINT OF VIEW |
Immunological aspects of determination of an adequate biological treatment sequence for inflammatory bowel diseases: the expert board statement (St. Petersburg, May 22, 2021) |
(Rus)
|
